Skip to main content

Animations

MJFF Publications

5951 - 5960 of 8808 Results
Title
Year
  • Year
  • 2021
  • 2018
  • 2017
  • 2018
  • 2013
  • 2017
  • 2016
  • 2018
  • 2014
  • 2022
  • Summary Details
    OPEN
    Title: Small Molecule Improvement of Trafficking Defects in Models of Neurodegeneration
    Journal Name: ACS Chemical Neuroscience
    Publisher: American Chemical Society (ACS)
    Publication Date:
    Open Access(OA) Status: OPEN
    License:
    DOI - Digital Object Identifier: 10.1021/acschemneuro.1c00524
    Citation Count: 1
  • Summary Details
    OPEN
    Title: Phenotypic Reprogramming of Striatal Neurons into Dopaminergic Neuron-like Cells in the Adult Mouse Brain
    Journal Name: Stem Cell Reports
    Publisher: Elsevier BV
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by-nc-nd
    DOI - Digital Object Identifier: 10.1016/j.stemcr.2018.09.004
    Citation Count: 43
  • Summary Details
    OPEN
    Title: No evidence for rare TRAP1 mutations influencing the risk of idiopathic Parkinson’s disease
    Journal Name: Brain
    Publisher: Oxford University Press (OUP)
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by-nc
    DOI - Digital Object Identifier: 10.1093/brain/awx378
    Citation Count: 8
  • Summary Details
    OPEN
    Title: PINK 1 autophosphorylation is required for ubiquitin recognition
    Journal Name: EMBO reports
    Publisher: Springer Science and Business Media LLC
    Publication Date:
    Open Access(OA) Status: OPEN
    License:
    DOI - Digital Object Identifier: 10.15252/embr.201744981
    Citation Count: 107
  • Summary Details
    OPEN
    Title: A strategy for the generation, characterization and distribution of animal models by The Michael J. Fox Foundation for Parkinson's Research
    Journal Name: Disease Models & Mechanisms
    Publisher: The Company of Biologists
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.1242/dmm.011940
    Citation Count: 37
  • Summary Details
    RESTRICTED
    Title: Feasibility and Safety of Multisite Tissue and Biofluid Sampling for Synuclein in Parkinson’s Disease: The Systemic Synuclein Sampling Study (S4) (P1.013)
    Journal Name: Neurology
    Publisher: Ovid Technologies (Wolters Kluwer Health)
    Publication Date:
    Open Access(OA) Status: RESTRICTED
    License:
    DOI - Digital Object Identifier: 10.1212/wnl.88.16_supplement.p1.013
    Citation Count: 0
  • Summary Details
    OPEN
    Title: Personality and reported quality of life in Parkinson's disease
    Journal Name: International Journal of Geriatric Psychiatry
    Publisher: Wiley
    Publication Date:
    Open Access(OA) Status: OPEN
    License:
    DOI - Digital Object Identifier: 10.1002/gps.4475
    Best OA location URL: http://doi.org/10.1002/gps.4475
    Citation Count: 24
  • Summary Details
    OPEN
    Title: Varying the rate of intravenous cocaine infusion influences the temporal dynamics of both drug and dopamine concentrations in the striatum
    Journal Name: European Journal of Neuroscience
    Publisher: Wiley
    Publication Date:
    Open Access(OA) Status: OPEN
    License:
    DOI - Digital Object Identifier: 10.1111/ejn.13941
    Citation Count: 20
  • Summary Details
    OPEN
    Title: EIF4G1 gene mutations are not a common cause of Parkinson's disease in the Japanese population
    Journal Name: Parkinsonism & Related Disorders
    Publisher: Elsevier BV
    Publication Date:
    Open Access(OA) Status: OPEN
    License:
    DOI - Digital Object Identifier: 10.1016/j.parkreldis.2014.03.004
    Citation Count: 15
  • Summary Details
    OPEN
    Title: Identification of risk genes for Alzheimer’s disease by gene embedding
    Journal Name: Cell Genomics
    Publisher: Elsevier BV
    Publication Date:
    Open Access(OA) Status: OPEN
    License: cc-by
    DOI - Digital Object Identifier: 10.1016/j.xgen.2022.100162
    Citation Count: 24
We use cookies to ensure that you get the best experience. By continuing to use this website, you indicate that you have read our Terms of Service and Privacy Policy.